Lingyu Dai

Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

Zhenyu Zhong, Dan Deng, Yu Gao et al. · The Lancet Rheumatology · 2024 · 29 citations

Life Sciences, Immunology, Pharmacotherapy +17

Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection

Zhenyu Zhong, Weiting Liao, Lingyu Dai et al. · Annals of the Rheumatic Diseases · 2021 · 21 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease

Zhenyu Zhong, Lingyu Dai, Qiuying Wu et al. · Nature Communications · 2023 · 13 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Risk for uveitis relapse after COVID-19 vaccination

Zhenyu Zhong, Qiuying Wu, Yuxian Lai et al. · Journal of Autoimmunity · 2022 · 12 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Identifying prioritization of therapeutic targets for ankylosing spondylitis: a multi-omics Mendelian randomization study

Lingyu Dai, Lan Xia, Guannan Su et al. · Journal of Translational Medicine · 2024 · 11 citations · Full text

Life Sciences, Bioinformatics, Genetics +17